Stock FAQs

why zy stock is down today

by Justen Kemmer Published 2 years ago Updated 2 years ago
image

Why are stocks down today?

Apr 11, 2022 · Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZY.

Why did zymergen (Zym) say it's losing sales from hyaline?

Aug 06, 2021 · Continuing the roller-coaster ride that it has been on this week, shares of Zymergen ( ZY -6.28% ) are plummeting Friday. As of 11:12 a.m. EDT, the stock was down by 14.1%. Two changes in the ...

Why are zymergen shares soaring today?

Aug 04, 2021 · What happened. Zymergen ( ZY 2.53%) stock got slammed this morning and had plunged 76% at 11:25 a.m. EDT, thanks to some jarring updates coming in from the "biofacturing" start-up that went public ...

Is the backdrop too negative for tech stocks?

Aug 04, 2021 · Zymergen Inc (NASDAQ: ZY) stock was down as much as 73.90% during today’s pre-market. According to metrics provided by MarketWatch, ZY stock traded around $9.80 as of August 4, 2021, 6:32 a.m. EDT.

See more

Find the latest Zymergen Inc. (ZY) stock quote, history, news and other vital information to help you with your stock trading and investing.

image

Is ZY a good stock to buy?

Out of 7 analysts, 0 (0%) are recommending ZY as a Strong Buy, 0 (0%) are recommending ZY as a Buy, 4 (57.14%) are recommending ZY as a Hold, 2 (28.57%) are recommending ZY as a Sell, and 1 (14.29%) are recommending ZY as a Strong Sell.

Is Zymergen publicly traded?

Common Stock

This is Zymergen Inc.'s initial public offering. We are offering shares of our common stock to be sold in this offering. We expect the public offering price to be between $ and $ per share of common stock. Prior to this offering, there has been no public market for our common stock.

What happened at Zymergen?

Zymergen's stock tanked 69% that day, wiping out nearly $2.5 billion in market value. The disclosure was shocking for a company that had raised more than $1 billion in venture funding and $530 million more in its IPO. Lawyers are suing on behalf of shareholders, and regulators are said to be scrutinizing the company.Oct 13, 2021

What went wrong at Zymergen?

However, Zymergen dropped a bomb in August when it ruled out any potential revenue in 2021 and 2022, citing technical issues with Hyaline among other things, and announced the abrupt exit of its then-CEO, Josh Hoffman.Oct 19, 2021

Who invested in Zymergen?

The round welcomes new investors Goldman Sachs and Hanwha Asset Management, as well as returning investors, DCVC (Data Collective), True Ventures, Two Sigma Ventures, DFJ and Innovation Endeavors.

Is Zymergen a good investment?

Zymergen has received a consensus rating of Hold. The company's average rating score is 1.63, and is based on no buy ratings, 5 hold ratings, and 3 sell ratings.

Is Zymergen a good company?

Is Zymergen a good company to work for? Zymergen has an overall rating of 3.1 out of 5, based on over 176 reviews left anonymously by employees. 50% of employees would recommend working at Zymergen to a friend and 25% have a positive outlook for the business.May 4, 2022

What industry is Zymergen in?

Biotechnology
Zymergen is an American biotechnology company based in Emeryville, California.
...
Zymergen.
TypePublic
IndustryBiotechnology
Founded2013
FoundersJed Dean, Josh Hoffman, Zach Serber
HeadquartersEmeryville, California
3 more rows

What does Zymergen make?

Zymergen develops genetically engineered microbes that are used for industrial fermentation. The company's approach merges automation and bioinformatics, which has been described as a combination of Darwinian selection of genetically engineered microbes combined with machine learning, analysis and automation.Dec 2, 2015

What is the Zymergen process?

Zymergen aims to manufacture products like films used in smart devices at 1/10th the cost of similar existing products using a process called biofacturing. Instead of using traditional petroleum-based raw materials, Zymergen will create biomolecules through fermentation and use them to manufacture products.

Is Zymergen's CEO stepping down?

Zymergen's sole product is staring at a bleak future, management suddenly isn't sure about the size of its target addressable market, and its CEO has stepped down abruptly. All in a day's time.

What was the net loss for Zymergen in 2021?

Net loss in the first quarter of 2021 was $84.6 million dollars. Cash and cash equivalents were $121.0 million as of March 31, 2021. Subsequent to quarter end, Zymergen completed its initial public offering in April 2021 raising approximately $530 million in net proceeds.

When will Zymergen report financial results?

Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021. EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021.

What is a zymergen?

About Zymergen Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries.

When will Zymergen report results for 2021?

(Nasdaq: ZY) today announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3rd, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. A webcast of the conference call can be accessed at https://investors.zymergen.com/. About Zymergen Zymergen is a bio

When is Zymergen's first quarter 2021?

Webcast Information Zymergen will host a conference call to discuss the first quarter 2021 financial results after market close on Monday, May 24, 2021 at 1:30 pm Pacific Time / 4:30 pm Eastern Time. A webcast of the conference call can be accessed at https://investors.zymergen.com/.

How much did hyaline raise?

The firm raised over $500 million and put over 18.5 million shares into circulation. The company’s IPO took place just four months after the public launch of the company’s first commercial product, Hyaline, a polymer film for use in electronic displays.

Who is the CEO of East Bay Synthetic Biology?

The moves are in line with acting CEO Jay Flatley 's plans to cut costs at the East Bay synthetic biology company, which just six months ago was a Wall Street darling with a $575 million IPO.

Stock Market Uncertainty on Oil and Fed Policy

The price of oil is central to the impact of Russia’s war since crude prices drive up inflation and slow down the economy. What happens with the price of oil will also have a big impact on whether the Fed pursues aggressive interest rates hikes starting at the upcoming March FOMC meeting.

Global Leaders Talk Sanctions on Russia, NATO on High Alert

U.K. Prime Minister Boris Johnson wasted little time this morning saying that his government would impose its “largest ever” economic sanctions on Russia, including freezing the assets of all major Russian banks, limiting cash held by Russian nationals in U.K. banks and sanctioning more than 100 individuals and entities.

CPI Inflation Flashed Warning Signs for the Fed

The recent January CPI report indicated that prices rose 7.5% in January year over year, registering the highest annualized growth in CPI inflation since February 1982.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9